Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis | Zendy

Felipe A. Montellano | Zendy; Kathrin Ungethüm | Zendy; Laura Ramiro | Zendy; Aliocu | Zendy; Simon Hellwig | Zendy; Felix Fluri | Zendy; William Whiteley | Zendy; Alejandro Bustamante | Zendy; Joan Montaner | Zendy; Peter U. Heuschmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis

Author(s) -

Felipe A. Montellano,

Kathrin Ungethüm,

Laura Ramiro,

Aliocu,

Simon Hellwig,

Felix Fluri,

William Whiteley,

Alejandro Bustamante,

Joan Montaner,

Peter U. Heuschmann

Publication year - 2021

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.120.029232

Subject(s) - medicine , stroke (engine) , ischemic stroke , cardiology , intensive care medicine , ischemia , mechanical engineering , engineering

Outcome prognostication in ischemic stroke patients remains challenging due to limited predictive properties of existing models. Blood-based biomarkers might provide additional information to established prognostic factors. We intended to identify the most promising prognostic biomarkers in ischemic stroke, their incremental prognostic value, and whether their predictive value differs among etiologies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research